Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.

Ilaria DicembriniEdoardo MannucciMatteo Monami Laura Pala

Published in: Diabetes, obesity & metabolism (2019)

The analysis showed that CSII, CGM and FGM provide only small benefits compared with MDI (on either HbA1c, hypoglycaemic risk or quality of life) in insulin-treated people with type 2 diabetes.

Keyphrases

type diabetes
glycemic control
insulin resistance
cardiovascular disease
low dose
adipose tissue
newly diagnosed
data analysis